Home page - Grindeks

JSC Grindeks invested €1.87 million to expand finished dosage form packaging capacity

JSC Grindeks has invested €1.87 million in a new packaging line at JSC Tallinna Farmaatsiatehas. During its first eight months of operation, the line produced...

Learn more..

JSC Grindeks subsidiary Ltd Grindeks Kalceks in Lithuania receives “Strongest in Lithuania 2026” recognition

JSC Grindeks’ subsidiary in Lithuania Ltd Grindeks Kalceks has received the “Strongest in Lithuania 2026” (Stipriausi Lietuvoje) recognition, confirming the company’s financial stability, reliability and...

Learn more..

JSC Grindeks Expands into the UK Market with First Topical Corticosteroid Product Registration

JSC Grindeks is pleased to announce a significant milestone in its product portfolio expansion: the successful registration of betamethasone valerate cream in the United Kingdom....

Learn more..

Cardiologist and RSU Associate Professor Kārlis Trušinskis receives prestigious D. H. Grindel Award

On March 26, one of the most significant events in the Latvian healthcare sector, the ceremonial “Medical Excellence Awards” took place at the Splendid Palace...

Learn more..

Grindeks Group introduces CDMO and out-licensing services

Over the last decade, Grindeks has been focusing on its own brand portfolio, but under the new CEO we are shifting our business development strategy.

Learn more..

Jānis Romanovskis Appointed as CEO of JSC “Grindeks”

Changes have taken place in the Management Board of JSC Grindeks – Jānis Romanovskis has been appointed as the company’s Chairman of the Board.

Learn more..

Strong growth and strengthened market positions in Europe during the first half of Grindeks final transformation year

Financial results for “Grindeks” show that in the first half of 2025 – the company’s final year of transformation – the Group has achieved significant...

Learn more..

Endocrinologist and RSU Professor Ilze Konrade – This year’s D. H. Grindel award laureate

On Wednesday, 26 March, the prestigious “Annual Medicine Award” ceremony was held at the Splendid Palace cinema – one of the most significant events in Latvia’s...

Learn more..

Yellow Purple Gradient Registration Is Now Available Facebook Post

Grindeks honours excellence in pharmacy and medicine for 30 years

On March 26, the Latvian pharmaceutical company Grindeks will present the prestigious D. H. Grindel Award – the highest professional recognition for significant or lifetime...

Learn more..

Baltics leading pharmaceutical company Grindeks expands to new export markets worldwide

The leading pharmaceutical company in the Baltics, Grindeks, continues to strengthen its global presence by entering new export markets.

Learn more..

Grindeks supports the 32nd A. Krauklis Memorial Basketball Tournament

This year, “Grindeks” will support the 32nd Alfrēds Krauklis Memorial Basketball Tournament, which is the largest children’s and youth basketball event in the Baltics. The...

Learn more..

Career

News

Products

Make health your habit!

We are strongly and emotionally connected to health, so we encourage everyone to follow a healthy lifestyle.

Learn more..

Latest news

For health

Global

JSC Grindeks invested €1.87 million to expand finished dosage form packaging capacity

JSC Grindeks subsidiary Ltd Grindeks Kalceks in Lithuania receives “Strongest in Lithuania 2026” recognition

JSC Grindeks Expands into the UK Market with First Topical Corticosteroid Product Registration

Cardiologist and RSU Associate Professor Kārlis Trušinskis receives prestigious D. H. Grindel Award

Grindeks Group introduces CDMO and out-licensing services

Jānis Romanovskis Appointed as CEO of JSC “Grindeks”

Strong growth and strengthened market positions in Europe during the first half of Grindeks final transformation year

Endocrinologist and RSU Professor Ilze Konrade – This year’s D. H. Grindel award laureate

Grindeks honours excellence in pharmacy and medicine for 30 years

Baltics leading pharmaceutical company Grindeks expands to new export markets worldwide

Grindeks supports the 32nd A. Krauklis Memorial Basketball Tournament

Career

News

Products

Make health your habit!

Latest news

JSC Grindeks invested €1.87 million to expand finished dosage form packaging capacity

JSC Grindeks subsidiary Ltd Grindeks Kalceks in Lithuania receives “Strongest in Lithuania 2026” recognition

JSC Grindeks Expands into the UK Market with First Topical Corticosteroid Product Registration

For health

Cardiovascular system

Central Nervous System

Oncology

Diabetes

Dermatology

Global

Grindeks.com

JSC Grindeks invested €1.87 million to expand finished dosage form packaging capacity

JSC Grindeks subsidiary Ltd Grindeks Kalceks in Lithuania receives “Strongest in Lithuania 2026” recognition

JSC Grindeks Expands into the UK Market with First Topical Corticosteroid Product Registration

Cardiologist and RSU Associate Professor Kārlis Trušinskis receives prestigious D. H. Grindel Award

Grindeks Group introduces CDMO and out-licensing services

Jānis Romanovskis Appointed as CEO of JSC “Grindeks”

Strong growth and strengthened market positions in Europe during the first half of Grindeks final transformation year

Endocrinologist and RSU Professor Ilze Konrade – This year’s D. H. Grindel award laureate

Grindeks honours excellence in pharmacy and medicine for 30 years

Baltics leading pharmaceutical company Grindeks expands to new export markets worldwide

Grindeks supports the 32nd A. Krauklis Memorial Basketball Tournament

Career

News

Products

Make health your habit!

Latest news

JSC Grindeks invested €1.87 million to expand finished dosage form packaging capacity

JSC Grindeks subsidiary Ltd Grindeks Kalceks in Lithuania receives “Strongest in Lithuania 2026” recognition

JSC Grindeks Expands into the UK Market with First Topical Corticosteroid Product Registration

For health

Cardiovascular system

Central Nervous System

Oncology

Diabetes

Dermatology

Choose your country/region website

NOTE: A new country/region website selection will open in a new tab